罗林明, 楚世峰, 姜懿纳, 罗飘, 陈乃宏. 神经干细胞治疗胶质瘤的研究进展J. 药学学报, 2017,52(4): 510-516. doi: 10.16438/j.0513-4870.2016-1000
引用本文: 罗林明, 楚世峰, 姜懿纳, 罗飘, 陈乃宏. 神经干细胞治疗胶质瘤的研究进展J. 药学学报, 2017,52(4): 510-516. doi: 10.16438/j.0513-4870.2016-1000
LUO Lin-ming, CHU Shi-feng, JIANG Yi-na, LUO Piao, CHEN Nai-hong. Advance in the treatment of glioma by neural stem cells J. Acta Pharmaceutica Sinica, 2017,52(4): 510-516. doi: 10.16438/j.0513-4870.2016-1000
Citation: LUO Lin-ming, CHU Shi-feng, JIANG Yi-na, LUO Piao, CHEN Nai-hong. Advance in the treatment of glioma by neural stem cells J. Acta Pharmaceutica Sinica, 2017,52(4): 510-516. doi: 10.16438/j.0513-4870.2016-1000

神经干细胞治疗胶质瘤的研究进展

Advance in the treatment of glioma by neural stem cells

  • 摘要: 神经干细胞具有肿瘤趋向性,可向肿瘤细胞定向迁移;神经干细胞能跨越血脑屏障;而且在肿瘤微环境下,神经干细胞与肿瘤细胞优先接触,然后包围靶细胞。基于以上特性,可利用神经干细胞作为运输载体,将治疗病毒、酶/前药、基因或自杀基因等选择性靶向胶质瘤细胞。神经干细胞还可通过各种不同的基因修饰,以达到更可靠、更安全及更有效的胶质瘤治疗目的。

     

    Abstract: Neural stem cells (NSCs) posse the specialty of tumor tropism and be able to migrate specifically to tumor cells. NSCs are also cross the blood brain barrier. NSCs keep in touch with tumor cells preferentially under the tumor microenvironment, and surround the target cells. Based on these characteristics, NSCs can be used as a carrier for therapeutic virus, enzymes/prodrugs, genes or suicide genes, etc. which are selectively delivered to the glioma cells. NSCs may be modified by a variety of different genes to establish a reliable, safe and effective therapy for glioma.

     

/

返回文章
返回